News
- Author:
- Jim Kling
Publish date: October 24, 2022
A post hoc analysis shows that the drug works about as well in Lennox-Gastaut syndrome as in patients with pediatric encephalopathies.
News
- Author:
- Jim Kling
Publish date: October 24, 2022
After evaluation of an additional 3.4 years of observation, the authors found the safety profile of tofacitinib remained consistent with increased ...
News
- Author:
- Jim Kling
Publish date: October 21, 2022
Assessment schedules should be individualized and evidence-based to assess cancer recurrence.
News
- Author:
- Jim Kling
Publish date: October 21, 2022
Researchers hope to tease out mechanism of cardiovascular risk to improve monitoring and prevention.
News
- Author:
- Jim Kling
Publish date: October 20, 2022
“Infants who are at higher risk for developing cerebral palsy had more respiratory instability early on in life.”
News
- Author:
- Jim Kling
Publish date: October 18, 2022
Key movements could both aid diagnosis dystonia in patients with cerebral palsy and hint at differences in brain injury.
News
- Author:
- Jim Kling
Publish date: October 12, 2022
Equivalent efficacy and fewer procedures could make metal stents more cost-effective than plastic stents.
News
- Author:
- Jim Kling
Publish date: October 11, 2022
The research could eventually lead to identification of unique cells-of-origin for these tumors – as well as potential treatment targets.
News
- Author:
- Jim Kling
Publish date: October 11, 2022
Trainees had better outcomes and reported a better experience using water exchange than when using air insufflation.
News
- Author:
- Jim Kling
Publish date: October 10, 2022
The consensus paper defines subtypes for clinical and research purposes.
News
- Author:
- Jim Kling
Publish date: October 10, 2022
The consensus paper defines subtypes for clinical and research purposes.
News
- Author:
- Jim Kling
Publish date: October 6, 2022
A retrospective analysis suggests carboplatin is better than cetuximab as a radiosensitizing agent.
News
- Author:
- Jim Kling
Publish date: October 6, 2022
Novel biomarker combined with PD-L1 expression could indicate selection of immunotherapy and avoid chemotherapy toxicities in some patients.
News
- Author:
- Jim Kling
Publish date: September 28, 2022
Study authors suggest that reduced rectoanal gradient during high-resolution anorectal manometry could be enough reason to start biofeedback therap...
News
- Author:
- Jim Kling
Publish date: September 27, 2022
Sentinel node tumors 3 mm or larger should be considered for adjuvant therapy, while smaller sizes could be treated similarly to AJCC IB.
